Xact Kapitalforvaltning’s Momenta Pharmaceuticals, Inc. MNTA Stock Holding History

Xact Kapitalforvaltning’s Portfolio MNTA Stock Details MNTA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	$578K	Buy	21,260 +7,300	+52%	+$203K	0.01%	689
2019 Q4	$275K	Hold	13,960	–	–	﹤0.01%	1274
2019 Q3	$181K	Hold	13,960	–	–	﹤0.01%	1382
2019 Q2	$174K	Hold	13,960	–	–	﹤0.01%	1402
2019 Q1	$203K	Buy	13,960 +1,800	+15%	+$23K	﹤0.01%	1388
2018 Q4	$134K	Hold	12,160	–	–	﹤0.01%	1472
2018 Q3	$320K	Hold	12,160	–	–	0.01%	1323
2018 Q2	$249K	Buy	12,160 +500	+4%	+$10.7K	0.01%	1456
2018 Q1	$212K	Hold	11,660	–	–	﹤0.01%	1463
2017 Q4	$163K	Buy	+11,660	New	+$158K	﹤0.01%	1293

Other funds holding MNTA

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

RCM

RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Maverick Capital Dallas, Texas $8.67B AUM 48.76% 1-Year Est. Return

Xact Kapitalforvaltning's MNTA Position: Q1 2020 in Review

Xact Kapitalforvaltning increased its Momenta Pharmaceuticals, Inc. (MNTA) stake by 52% in Q1 2020, buying an estimated $203K and bringing the position to 21,260 shares worth $578K. The position accounts for 0.01% of the portfolio, ranked #689.

Xact Kapitalforvaltning first reported a position in MNTA in Q4 2017 and has held it in 10 quarters since. 199 funds tracked by Wall St. Rank hold MNTA as of Q1 2020.

Xact Kapitalforvaltning held 21,260 shares of Momenta Pharmaceuticals, Inc. worth $578K as of Q1 2020.
Xact Kapitalforvaltning bought 7,300 Momenta Pharmaceuticals, Inc. shares in Q1 2020, an estimated $203K.
Momenta Pharmaceuticals, Inc. made up 0.01% of Xact Kapitalforvaltning's portfolio in Q1 2020, its #689 holding.
Xact Kapitalforvaltning first reported a position in Momenta Pharmaceuticals, Inc. in Q4 2017 and has held it in 10 quarters since.
199 funds tracked by Wall St. Rank held Momenta Pharmaceuticals, Inc. as of Q1 2020.

Based on Xact Kapitalforvaltning's 13F filing for Q1 2020, filed 14 May 2020.